HIV-cholesterol connection suggests a new antiretroviral strategy
- PMID: 20076496
- PMCID: PMC1629035
- DOI: 10.1371/journal.pbio.0040400
HIV-cholesterol connection suggests a new antiretroviral strategy
Figures
Comment on
-
Human immunodeficiency virus impairs reverse cholesterol transport from macrophages.PLoS Biol. 2006 Oct;4(11):e365. doi: 10.1371/journal.pbio.0040365. PLoS Biol. 2006. PMID: 17076584 Free PMC article.
Similar articles
-
[Serum leptin and adiponectin concentrations in patients infected with human immunodeficiency virus type 1 (HIV-1) on antiretroviral therapy].Endokrynol Pol. 2005 Jan-Feb;56(1):19-24. Endokrynol Pol. 2005. PMID: 16335669 Polish.
-
Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone.HIV Med. 2005 Nov;6(6):396-402. doi: 10.1111/j.1468-1293.2005.00325.x. HIV Med. 2005. PMID: 16268821
-
Dyslipidaemia in HIV-infected patients: association with adherence to potent antiretroviral therapy.Int J STD AIDS. 2001 Jul;12(7):463-8. doi: 10.1258/0956462011923507. Int J STD AIDS. 2001. PMID: 11394983
-
Dyslipidemia in HIV-infected individuals.Braz J Infect Dis. 2010 Nov-Dec;14(6):575-88. doi: 10.1016/s1413-8670(10)70115-x. Braz J Infect Dis. 2010. PMID: 21340298 Review.
-
Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system.Curr Opin Neurol. 2006 Aug;19(4):358-61. doi: 10.1097/01.wco.0000236614.51592.ca. Curr Opin Neurol. 2006. PMID: 16914973 Review.
Publication types
LinkOut - more resources
Full Text Sources